P-cadherin potentiates ligand-dependent EGFR and IGF-1R signaling in dysplastic and malignant oral keratinocytes

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2541-2548

  Lysne, Desseree ^a   Johns, James ^a   Walker, Andrew ^a   Ecker, Rachel ^a   Fowler, Christopher ^a   Lawson, Kathryn R ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

AKT; Epidermal growth factor receptor; Insulin like growth factor 1 receptor; Mitogen activated protein kinase; Oral squamous cell carcinoma; P cadherin; Snail

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; P CADHERIN; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR SNAIL; CADHERIN; CDH3 PROTEIN, HUMAN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR; IGF1 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; SOMATOMEDIN C; TRANSCRIPTION FACTOR;

ARTICLE; CELL MOTILITY; CELL STRUCTURE; DYSPLASIA; GENETIC TRANSCRIPTION; INTERNALIZATION; KERATINOCYTE; ORAL CANCER CELL LINE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL MOTION; CELL SHAPE; EPITHELIAL MESENCHYMAL TRANSITION; GENETICS; HUMAN; METABOLISM; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MOUTH MUCOSA; MOUTH NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; TRANSCRIPTION FACTORS;

EID: 84914705816     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3545     Document Type: Article

References (39)

1. Warnakulasuriya S: Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45: 309-316, 2009.
2. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
3. Santos-García A, Abad-Hernández MM, Fonseca-Sánchez E, et al: E-caderin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Med Oral Path Oral Cir Bucal 11: E100-E105, 2006 (In English and Spanish).
4. Birchmeier W and Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198: 11-26, 1994.
5. Shimoyama Y, Hirohashi S, Hirano S, et al: Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 49: 2128-2133, 1989
6. Van Marck V, Stove C, Jacobs K, Van den Eynden G and Bracke M: P-cadherin in adhesion and invasion: Opposite roles in colon and bladder carcinoma. Int J Cancer 128: 1031-1044, 2011.
7. Van Marck V, Stove C, Van Den Bossche K, et al: P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res 65: 8774-8783, 2005.
8. Paredes J, Albergaria A, Oliveira J T, Jerónimo C, Milanezi F and Schmitt FC: P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDh3 promoter hypomethylation. Clin Cancer Res 11: 5869-5877, 2005.
9. Bagutti C, Speight PM and Watt FM: Comparison of integrin, cadherin and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 186: 8-16, 1998.
10. Williams HK, Sanders DS, Jankowski JA, Landini G and Brown AM: Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med 27: 308-317, 1998.
11. Muñoz-Guerra MF, Marazuela EG, Fernández-Contreras ME and Gamallo C: P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis. Cancer 103: 960-969, 2005.
12. Lo Muzio L, Pannone G, Mignogna M, et al: P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas. Histol Histopathol 19: 1089-1099, 2004.
13. Bedzhov I, Liszewska E, Kanzler B and Stemmler MP: IGF1R signaling is indispensable for preimplantation development and is activated via a novel function of E-cadherin. PLoS Genet 8: e1002609, 2012.
14. Bryant DM, Wylie FG and Stow JL: Regulation of endocytosis, nuclear translocation and signaling of fibroblast growth factor receptor 1 by E-cadherin. Mol Biol Cell 16: 14-23, 2005.
15. Qian X, Karpova T, Sheppard AM, McNally J and Lowy DR: E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J 23: 1739-1784, 2004.
16. Suyama K, Shapiro I, Guttman M and Hazan RB: A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301-314, 2002.
17. Cheung LW, Mak AS, Cheung AN, Ngan HY, Leung PC and Wong AS: P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin. Oncogene 30: 2964-2974, 2011.
18. Johnson KR, Lewis JE, Li D, et al: P- and E-cadherin are in separate complexes in cells expressing both cadherins. Exp Cell Res 207: 252-260, 1993.
19. Ireton RC, Davis MA, Van Hengel J, et al: A novel role for p120 catenin in E-cadherin function. J Cell Biol 159: 465-476, 2002.
20. Maeda M, Johnson E, Mandal SH, et al: Expression of inappropriate cadherins by epithelial tumor cells promotes endocytosis and degradation of E-cadherin via competition for p120(ctn). Oncogene 25: 4595-4604, 2006.
21. Joseph BK and Sundaram DB: Insulin-like growth factor-1 receptor expression in oral squamous cell carcinoma. J Clin Exp Invest 2, 354-361, 2011.
22. Morali OG, Delmas V, Moore R, Jeanney C, Thiery JP and Larue L: IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20: 4942-4950, 2001.
23. Chavez MG, Buhr CA, Petrie WK, Wandinger-Ness A, Kusewitt DF and Hudson LG: Differential downregulation of E-cadherin and desmoglein by epidermal growth factor. Dermatol Res Pract 2012: 309-587, 2012.
24. Kim HJ, Litzenburger BC, Cui X, et al: Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-κB and Snail. Mol Cell Biol 27: 3165-3175, 2007.
25. Zhou BP, Deng J, Xia W, et al: Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6: 931-940, 2004.
26. Sutherland C, Leighton IA and Cohen P: Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296: 15-19, 1993.
27. Bauer K, Dowejko A, Bosserhoff AK, Reichert T and Bauer RJ: P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation. Carcinogenesis 30: 1781-1788, 2009.
28. Hiraishi Y, Wada T, Nakatani K, Negoro K and Fujita S: Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas. Pathol Oncol Res 12: 87-91, 2006.
29. Lo Muzio L, Campisi G, Farina A, et al: P-cadherin expression and survival rate in oral squamous cell carcinoma: an immuno-histochemical study. BMC Cancer 5: e63, 2005.
30. Lozano E, Betson M and Braga VM: Tumor progression: small GTPases and loss of cell-cell adhesion. Bioessays 25: 452-463, 2003.
31. Taniuchi K, Nakagawa H, Hosokawa M, et al: Overexpressed P-cadherin/CDh3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res 65: 3092-3099, 2005.
32. Zhang A, Wang Q, Han Z, et al: Reduced expression of Snail decreases breast cancer cell motility by downregulating the expression and inhibiting the activity of RhoA GTPase. Oncol Lett 6: 339-346, 2013.
33. Taelman VF, Dobrowolski R, Plouhinec JL, et al: Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143: 1136-1148, 2010.
34. Usami Y, Satake S, Nakayama F, et al: Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol 215: 330-339, 2008.
35. Chang SE, Foster S, Betts D and Marnock WE: DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype. Int J Cancer 52: 896-902, 1992.
36. Tsui IF, Poh CF, Garnis C, Rosin MP, Zhang L and Lam WL: Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias. Int J Cancer 125: 2219-2228, 2009.
37. Grille SJ, Bellacosa A, Upson J, et al: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178, 2003.
38. Reddy KB, Krueger JS, Kondapaka SB and Diglio CA: Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer 82: 268-273, 1999.
39. Klemke RL, Cai S, Giannini AL, Gallagher PJ, De Lanerolle P and Cheresh DA: Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137: 481-492, 1997.